Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

NPA Insurance enhances locum pharmacist professional indemnity policy

Locum pharmacists' indemnity insurance npa
Healthcare professionals working in a medication store. locum pharmacists

Under the updated policy, locum pharmacists will no longer pay charges for vaccine administration

NPA Insurance, a wholly owned subsidiary of the National Pharmacy Association (NPA), has updated its professional indemnity policy for locum pharmacists to better support their expanding roles in healthcare.

The enhanced policy now includes private and NHS prescribing cover for weight loss and other areas of competence, which is available for locums working in pharmacy, general practice and hospital settings.


Policyholders will benefit from an extended range of cover, which includes, as standard, the delivery of the NHS Pharmacy First service, the expanded pharmacy contraception service, and the re-launched hypertension case-finding service.

Moreover, NPA Insurance has removed charges for vaccine administration, including COVID-19, flu, and travel.

Locum pharmacists will also have access to NPA Insurance’s award-winning claims team as part of the new policy.

For those involved in specialised treatments, locum pharmacists can purchase additional cover for both NHS and private independent prescribing. This includes cover for procedures like Botox administration, non-permanent dermal fillers, and cryotherapy.

The insurance company also offers bespoke policies tailored to specialist needs, and designated prescribing practitioner cover, enabling training of newly qualified independent prescribers.

Lisa Banks, MD of NPA Pharmacy Insurance, commented on the policy enhancement: “Our unrivalled knowledge and legal perspective to protection provides our policyholders with a genuinely holistic approach to risk and claims management.”

She pointed out that, unlike other pharmacy indemnity providers, NPA Insurance acts as the underwriter and makes “decisions on cover which are not restrained by bureaucratic processes, or changes in risk appetite.”

“We can flex our agility to provide bespoke insurance solutions for each individual case, and our qualified lawyers have the autonomy to make quick and informed decisions,” she added.

In addition to the enhanced indemnity cover, locum policyholders can access a range of NPA’s online resources at a discounted price.

There’s more: policyholders can become an NPA Associated Pharmacist and gain access to training, an advice and support line for clinical queries, drug tariff and medicine safety guidance, and SOPs.

More For You

Home cervical screening kits in England

Government data states that around five million women are still not attending cervical screenings

Getty Images

Home cervical screening kits launched in England

Key Summary

  • NHS England has launched at-home cervical screening kits to improve uptake among women aged 25 to 64.
  • The discreet kits aim to overcome barriers like embarrassment and increase screening rates from 68.8 per cent towards the 80 per cent target.
  • Early diagnosis through home testing is expected to boost survival rates and help tackle cervical cancer for all communities.

NHS England has created an innovative at-home human papillomavirus (HPV) testing, for women who are yet to take cervical screening service.

Keep ReadingShow less
NHS warns doctors using unapproved  AI Software

NHS England has demanded that GPs and hospitals stop using artificial intelligence software that could breach data protection rules.

iStock

NHS warns doctors against use of unapproved AI software

Key Summary

  • NHS wants GPs and hospitals to stop using dubious artificial intelligence software during patient meetings
  • It had in April urged the doctors to use AI for notetaking using Ambient Voice Technology software
  • But it now claims that many AVT suppliers, who fail to meet NHS governance standards, are selling them to doctors
  • British Medical Association officials want the NHS to help doctors choose the safe AVT software

Doctors have been warned against the use of AI software that does not meet minimum standards to record and transcribe patient meetings.

Keep ReadingShow less
Mother holding newborn baby during early postnatal care in NHS maternity setting

Mother with newborn in NHS maternity care

Getty Images

Failing maternity services leads to nation-wide inquiry

Key Summary
  • Wes Streeting has ordered a national inquiry into failing NHS maternity and neonatal services
  • The review will start this summer, focusing first on the worst-performing units
  • A second phase will examine the entire system and propose national improvements
  • The inquiry will tackle racial inequalities and maternity mortality disparities

Health Secretary Wes Streeting has commissioned a nation-wide inquiry due to the rise in the number of failing maternity and neonatal services in the country.

NHS trusts such as Morecambe Bay, Shrewsbury and Telford, East Kent, Nottingham and Leeds are some of the names on the worst-performing list.

Keep ReadingShow less
UK globally competitive in life sciences

The Industrial Strategy has identified eight high-growth potential sectors, including life sciences.

iStock

Key test will be to make UK globally competitive in life sciences: ABPI

Key Summary

  • The Industrial Strategy has identified life sciences as one of its high-growth potential sectors
  • ABPI wants the UK to become a leading centre for life sciences research and development
  • It wants the government to move quickly from planning to delivery

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the government’s new Industrial Strategy, but said the key test for life sciences will be whether it can return the UK to international competitiveness.

Keep ReadingShow less
Screening newborn babies for rare diseases will involve sequencing their complete DNA

Screening newborn babies for rare diseases will involve sequencing their complete DNA

iStock

DNA test for all babies to study disease risk

Key Summary

  • The DNA of newborn babies will be sequenced using blood samples from their umbilical cord
  • The government will invest £650m in DNA research for all patients by 2030
  • Genomics and AI would be used for faster diagnoses

Children born in England will have their DNA mapped to screen for hundreds of diseases under the NHS plan for the next 10 years.

Keep ReadingShow less